The CO-Regulation Database (CORD): A tool to identify coordinately expressed genes

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Fahrenbach, John P ^a   Andrade, Jorge ^a   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MYOD1 PROTEIN; VIMENTIN; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE 4; MYOD PROTEIN; MYOD1 MYOGENIC DIFFERENTIATION PROTEIN; TRANSCRIPTOME;

ARTICLE; CDKN2A GENE; CO REGULATION DATABASE; DATA BASE; GENE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC CORRELATION; HUMAN; MICROARRAY ANALYSIS; MOUSE; MYOD1 GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; VIM GENE; COMPUTER PROGRAM; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; METABOLISM; NEOPLASM; TUMOR SUPPRESSOR GENE;

CYCLIN-DEPENDENT KINASE 4; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; GENES, P16; HUMANS; MYOD PROTEIN; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SOFTWARE; TRANSCRIPTOME; VIMENTIN;

EID: 84897125250     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090408     Document Type: Article

References (43)

1. Rung J, Brazma A (2013) Reuse of public genome-wide gene expression data. Nat Rev Genet 14: 89-99.
2. Lepoivre C, Bergon A, Lopez F, Perumal NB, Nguyen C, et al. (2012) TranscriptomeBrowser 3.0: introducing a new compendium of molecular interactions and a new visualization tool for the study of gene regulatory networks. BMC Bioinformatics 13: 19.
3. Lopez F, Textoris J, Bergon A, Didier G, Remy E, et al. (2008) TranscriptomeBrowser: a powerful and flexible toolbox to explore productively the transcriptional landscape of the Gene Expression Omnibus database. PLoS One 3: e4001.
4. Engreitz JM, Morgan AA, Dudley JT, Chen R, Thathoo R, et al. (2010) Content-based microarray search using differential expression profiles. BMC Bioinformatics 11: 603.
5. Kapushesky M, Adamusiak T, Burdett T, Culhane A, Farne A, et al. (2012) Gene Expression Atlas update-a value-added database of microarray and sequencing-based functional genomics experiments. Nucleic Acids Res 40: D1077-1081.
6. Chen R, Mallelwar R, Thosar A, Venkatasubrahmanyam S, Butte AJ (2008) GeneChaser: identifying all biological and clinical conditions in which genes of interest are differentially expressed. BMC Bioinformatics 9: 548.
7. Obayashi T, Okamura Y, Ito S, Tadaka S, Motoike IN, et al. (2013) COXPRESdb: a database of comparative gene coexpression networks of eleven species for mammals. Nucleic Acids Res 41: D1014-1020.
8. Adler P, Kolde R, Kull M, Tkachenko A, Peterson H, et al. (2009) Mining for coexpression across hundreds of datasets using novel rank aggregation and visualization methods. Genome Biol 10: R139.
9. Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, et al. (2008) Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics 2008: 420747.
10. Kupershmidt I, Su QJ, Grewal A, Sundaresh S, Halperin I, et al. (2010) Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One 5.
11. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
12. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B57: 289-300.
13. Venet D, Dumont JE, Detours V (2011) Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput Biol 7: e1002240.
14. Rayess H, Wang MB, Srivatsan ES (2012) Cellular senescence and tumor suppressor gene p16. Int J Cancer 130: 1715-1725.
15. Rocco JW, Sidransky D (2001) p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp Cell Res 264: 42-55. (Pubitemid 32989080)
16. Surowiak P, Materna V, Maciejczyk A, Pudelko M, Suchocki S, et al. (2008) Decreased expression of p16 in ovarian cancers represents an unfavourable prognostic factor. Histol Histopathol 23: 531-538. (Pubitemid 351552339)
17. Schneider-Stock R, Boltze C, Lasota J, Peters B, Corless CL, et al. (2005) Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study. Clin Cancer Res 11: 638-645. (Pubitemid 40116890)
18. Fischer CA, Kampmann M, Zlobec I, Green E, Tornillo L, et al. (2010) p16 expression in oropharyngeal cancer: its impact on staging and prognosis compared with the conventional clinical staging parameters. Ann Oncol 21: 1961-1966.
19. Powell EL, Leoni LM, Canto MI, Forastiere AA, Iocobuzio-Donahue CA, et al. (2005) Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications. Am J Surg Pathol 29: 1497-1504. (Pubitemid 41513300)
20. Tinguely M, Jenni B, Knights A, Lopes B, Korol D, et al. (2008) MAGE-C1/CT-7 expression in plasma cell myeloma: sub-cellular localization impacts on clinical outcome. Cancer Sci 99: 720-725. (Pubitemid 351448075)
21. Mattila H, Schindler M, Isotalo J, Ikonen T, Vihinen M, et al. (2011) NMD and microRNA expression profiling of the HPCX1 locus reveal MAGEC1 as a candidate prostate cancer predisposition gene. BMC Cancer 11: 327.
22. Ivaska J (2011) Vimentin: Central hub in EMT induction? Small GTPases 2: 51-53.
23. Eckes B, Dogic D, Colucci-Guyon E, Wang N, Maniotis A, et al. (1998) Impaired mechanical stability, migration and contractile capacity in vimentin-deficient fibroblasts. J Cell Sci 111 (Pt 13): 1897-1907. (Pubitemid 28370534)
24. Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, et al. (2011) Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 30: 1436-1448.
25. Satelli A, Li S (2011) Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 68: 3033-3046.
26. Moinova H, Leidner RS, Ravi L, Lutterbaugh J, Barnholtz-Sloan JS, et al. (2012) Aberrant vimentin methylation is characteristic of upper gastrointestinal pathologies. Cancer Epidemiol Biomarkers Prev 21: 594-600.
27. Lahat G, Zhu QS, Huang KL, Wang S, Bolshakov S, et al. (2010) Vimentin is a novel anti-cancer therapeutic target; insights from in vitro and in vivo mice xenograft studies. PLoS One 5: e10105.
28. Davis RL, Weintraub H, Lassar AB (1987) Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000.
29. Bryson-Richardson RJ, Currie PD (2008) The genetics of vertebrate myogenesis. Nat Rev Genet 9: 632-646. (Pubitemid 352019755)
30. Bentzinger CF, Wang YX, Rudnicki MA (2012) Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4.
31. Olson EN (1993) Regulation of muscle transcription by the MyoD family. The heart of the matter. Circ Res 72: 1-6.
32. Tapscott SJ (2005) The circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132: 2685-2695.
33. Francetic T, Li Q (2011) Skeletal myogenesis and Myf5 activation. Transcription 2: 109-114.
34. Maschler S, Gebeshuber CA, Wiedemann EM, Alacakaptan M, Schreiber M, et al. (2010) Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med 2: 401-414.
35. Komatsu K, Andoh A, Ishiguro S, Suzuki N, Hunai H, et al. (2000) Increased expression of S100A6 (Calcyclin), a calcium-binding protein of the S100 family, in human colorectal adenocarcinomas. Clin Cancer Res 6: 172-177. (Pubitemid 30064991)
36. de Graauw M, Tijdens I, Smeets MB, Hensbergen PJ, Deelder AM, et al. (2008) Annexin A2 phosphorylation mediates cell scattering and branching morphogenesis via cofilin Activation. Mol Cell Biol 28: 1029-1040. (Pubitemid 351160059)
37. Van den Abbeele A, De Corte V, Van Impe K, Bruyneel E, Boucherie C, et al. (2007) Downregulation of gelsolin family proteins counteracts cancer cell invasion in vitro. Cancer Lett 255: 57-70. (Pubitemid 47212607)
38. Guweidhi A, Kleeff J, Adwan H, Giese NA, Wente MN, et al. (2005) Osteonectin influences growth and invasion of pancreatic cancer cells. Ann Surg 242: 224-234. (Pubitemid 41033439)
39. Ebralidze A, Tulchinsky E, Grigorian M, Afanasyeva A, Senin V, et al. (1989) Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. Genes Dev 3: 1086-1093.
40. Li LW, Yu XY, Yang Y, Zhang CP, Guo LP, et al. (2009) Expression of esophageal cancer related gene 4 (ECRG4), a novel tumor suppressor gene, in esophageal cancer and its inhibitory effect on the tumor growth in vitro and in vivo. Int J Cancer 125: 1505-1513.
41. Gjerdrum C, Tiron C, Hoiby T, Stefansson I, Haugen H, et al. (2010) Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival. Proc Natl Acad Sci U S A 107: 1124-1129.
42. Hellman NE, Spector J, Robinson J, Zuo X, Saunier S, et al. (2008) Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J Biol Chem 283: 4272-4282.
43. Umezu T, Yamanouchi H, Iida Y, Miura M, Tomooka Y (2010) Follistatin-like-1, a diffusible mesenchymal factor determines the fate of epithelium. Proc Natl Acad Sci U S A 107: 4601-4606.